Recent Quarter Total Invested
$80.33 M
Recent Quarter Institutional Ownership Percentage
71.29%
Total Invested of Last Quarter
$59.76 M
Ownership Percentage of Last Quarter
74.34%
Aclaris Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BML CAPITAL MANAGEMENT, LLC | 11/05/2024 | 14.25 M | $16.39 M | 9.72% | 19.96% |
| D. E. SHAW & CO., INC. | 11/14/2024 | 3.37 M | $3.88 M | 1.56% | 4.72% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2024 | 3.01 M | $3.46 M | -9.93% | 4.21% |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 11/14/2024 | 2.75 M | $3.17 M | 0.00% | 3.86% |
| STONEPINE CAPITAL MANAGEMENT, LLC | 11/13/2024 | 2.46 M | $2.83 M | 27.57% | 3.44% |
| ACADIAN ASSET MANAGEMENT LLC | 11/12/2024 | 2.08 M | $2.39 M | 8.61% | 2.91% |
| TRIUM CAPITAL LLP | 10/07/2024 | 1.91 M | $2.20 M | 1.11% | 2.68% |
| BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 1.71 M | $1.97 M | 100.00% | 2.40% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2024 | 1.37 M | $1.58 M | 48.63% | 1.92% |
| TWO SIGMA ADVISERS, LP | 11/14/2024 | 1.30 M | $1.50 M | -9.42% | 1.82% |
| ALDEBARAN CAPITAL, LLC | 11/13/2024 | 1.04 M | $1.20 M | 21.56% | 1.46% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 11/14/2024 | 915,509 | $1.05 M | 100.00% | 1.28% |
| TWO SIGMA INVESTMENTS, LP | 11/14/2024 | 907,916 | $1.04 M | -18.43% | 1.27% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 846,446 | $973,577 | 9.34% | 1.19% |
| SAMSARA BIOCAPITAL, LLC | 11/14/2024 | 696,171 | $800,597 | 0.00% | 0.98% |
| ACUITAS INVESTMENTS, LLC | 11/07/2024 | 578,139 | $664,860 | 24.57% | 0.81% |
| PALO ALTO INVESTORS LP | 11/14/2024 | 569,832 | $655,307 | 0.00% | 0.80% |
| MORGAN STANLEY | 11/14/2024 | 480,773 | $552,889 | 158.00% | 0.67% |
| AISLING CAPITAL MANAGEMENT LP | 11/13/2024 | 434,455 | $499,623 | 0.00% | 0.61% |
| CITADEL ADVISORS LLC | 11/14/2024 | 364,567 | $419,252 | -58.35% | 0.51% |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 11/08/2024 | 332,406 | $382,267 | 187.60% | 0.47% |
| HIGHTOWER ADVISORS, LLC | 11/14/2024 | 305,814 | $352,000 | -2.21% | 0.43% |
| GOLDMAN SACHS GROUP INC | 11/14/2024 | 301,556 | $346,789 | -67.10% | 0.42% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 11/14/2024 | 292,845 | $336,772 | -68.87% | 0.41% |
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 11/15/2024 | 264,377 | $304,034 | 0.00% | 0.37% |
| GSA CAPITAL PARTNERS LLP | 11/05/2024 | 255,032 | $293,000 | -24.25% | 0.36% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 11/14/2024 | 199,119 | $228,987 | 32.13% | 0.28% |
| STATE STREET CORP | 11/14/2024 | 188,721 | $217,029 | -4.02% | 0.26% |
| ASSENAGON ASSET MANAGEMENT S.A. | 10/23/2024 | 185,777 | $213,644 | 100.00% | 0.26% |
| SQUAREPOINT OPS LLC | 11/14/2024 | 140,580 | $161,667 | 48.47% | 0.20% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 11/14/2024 | 139,400 | $161,000 | 0.00% | 0.20% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 11/14/2024 | 90,000 | $103,500 | 100.00% | 0.13% |
| MARQUETTE ASSET MANAGEMENT, LLC | 10/08/2024 | 83,979 | $96,576 | 0.00% | 0.12% |
| DIMENSIONAL FUND ADVISORS LP | 11/07/2024 | 76,810 | $88,332 | 0.07% | 0.11% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 62,408 | $71,769 | -69.79% | 0.09% |
| BBR PARTNERS, LLC | 11/13/2024 | 60,000 | $69,000 | 0.00% | 0.08% |
| POINT72 ASIA (SINGAPORE) PTE. LTD. | 11/14/2024 | 52,052 | $59,860 | -51.77% | 0.07% |
| MARINER, LLC | 11/13/2024 | 48,101 | $55,316 | 13.99% | 0.07% |
| CAMBRIDGE INVESTMENT RESEARCH ADVISORS, INC. | 10/28/2024 | 41,873 | $48,000 | 0.00% | 0.06% |
| ENGINEERS GATE MANAGER LP | 11/14/2024 | 38,794 | $44,613 | -35.92% | 0.05% |
| TUDOR INVESTMENT CORP ET AL | 11/14/2024 | 33,183 | $38,160 | 0.00% | 0.05% |
| UBS GROUP AG | 11/14/2024 | 31,852 | $36,631 | -5.74% | 0.04% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 27,100 | $31,165 | 41.15% | 0.04% |
| SHAY CAPITAL LLC | 11/14/2024 | 27,000 | $31,050 | 100.00% | 0.04% |
| BARCLAYS PLC | 11/19/2024 | 20,393 | $23,000 | -49.33% | 0.03% |
| VONTOBEL HOLDING LTD. | 10/16/2024 | 20,000 | $23,000 | 0.00% | 0.03% |
| ALGERT GLOBAL LLC | 11/12/2024 | 19,770 | $23,000 | 67.83% | 0.03% |
| AJOVISTA, LLC | 11/12/2024 | 17,455 | $20.07 M | 100.00% | 0.02% |
| 11/14/2024 | 14,000 | $16,100 | 100.00% | 0.02% | |
| CHINA UNIVERSAL ASSET MANAGEMENT CO., LTD. | 10/25/2024 | 13,722 | $15,780 | 63.90% | 0.02% |
Aclaris Therapeutics, Inc.institutional Ownership - Frequently Asked Questions
-
Who are the largest shareholders of ACRS shares?
During the previous two years, 120 institutional investors and hedge funds held shares of Aclaris Therapeutics, Inc.. The most heavily invested institutionals were:
BML Capital Management, LLC: 14.25 M
D. E. Shaw & Co., Inc.: 3.37 M
MILLENNIUM MANAGEMENT LLC: 3.01 M
Rock Springs Capital Management LP: 2.75 M
Stonepine Capital Management, LLC: 2.46 M
ACADIAN ASSET MANAGEMENT LLC: 2.08 M
-
What percentage of Aclaris Therapeutics, Inc. stock is owned by institutional investors?
71.29% of Aclaris Therapeutics, Inc. stock is owned by institutional investors.
-
How much institutional buying is happening at ACRS ?
Institutional investors have bought a total of 51.60 M shares in the last 24 months. This purchase volume represents approximately $222.91 M in transactions.